CELC
Celcuity Inc.
Key Financials
Net Income
$-177042000
↓ 58.4%
Total Assets
$466.6M
↑ 90.3%
EPS (Diluted)
$-3.79
↓ 33.9%
Operating Income
$-172192000
↓ 52.0%
Shareholders' Equity
$100.6M
↓ 13.0%
Total Liabilities
$366.0M
↑ 182.6%
Cash & Equivalents
$165.7M
↑ 636.0%
Long-term Debt
$137.5M
↑ 30.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 10/2/2026 | View on SEC |
| 8-K | 9/30/2026 | View on SEC |
| 8-K | 8/26/2026 | View on SEC |
| 4 | 8/18/2026 | View on SEC |
| 4 | 8/18/2026 | View on SEC |
| 4 | 8/18/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| SCHEDULE 13G | 8/11/2026 | View on SEC |
| SCHEDULE 13G | 7/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CELC |
| Company Name | Celcuity Inc. |
| CIK | 1603454 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 763-392-0767 |